European Pharma & Biotech Patent Litigation Year in Review: The Top 5 Most Critical Developments from 2021
Head of Patent Litigation Strategy
Bristows LLP (U.K)
Ruud van der Velden
Global pharmaceutical and biotech patent law is an ever-changing battleground, and the past twenty months only amplified existing struggles for control of increasingly competitive intellectual property rights. With a historic 2021 behind us, renowned thought leaders from the European life sciences patent bar will take stock of the most important developments from the past year, and offer best practices on how to manage increasing, overlapping, and uncertain risk factors.
Reproducing the webinar either audio or video is not permitted without prior express written consent of C5 Communications. Speaker permission must be obtained for use of presentation content in news coverage/articles.